We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phorm Corp | LSE:PHRM | London | Ordinary Share | SG9999009278 | ORD NPV (DI) |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 1.00 | GBX |
Phorm Corp (PHRM) Share Charts1 Year Phorm Corp Chart |
|
1 Month Phorm Corp Chart |
Intraday Phorm Corp Chart |
Date | Time | Title | Posts |
---|---|---|---|
22/3/2023 | 08:11 | Phorm (PHRM) - Google or Microsoft must be after it | 51,684 |
16/4/2016 | 21:37 | Doing well this morning. | 5 |
16/4/2016 | 21:37 | PHRM IS GOING INTO SUSPENSION - AVOID THIS STOCK - **** WARNING ****** | 4 |
16/4/2016 | 21:37 | Phorm - AVOID !! | 50 |
16/4/2016 | 21:36 | AVG has decided not to detect Phorm cookies | 5 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 02/8/2017 08:19 by knigel LOL! Made money here? Only by trading the spikes..Unless you shorted the share... Goodbye! |
Posted at 03/10/2016 22:17 by btcustomer Interesting to see that our resident rampers don't appear to be able to differentiate between Phluid Media Inc and its parent company, Phorm corporation (Singapore) Ltd. There is, as yet, no evidence that Phorm Corporation has been wound up, merely one of its wholly owned UK subsidiaries.They're not very good at this are they? Keep your eye on Keith Little (ex BT, ex BBC) - he's been in business with Andrew Croxson since 8th March 2016 - about 12 days after Phorm shares were suspended from AIM and just over three months before Mr Little presented his winding up petition for PhluidMedia Inc in the High Court. Now who was Mr Little working for from 2012 to the "present" ? Experience CTO Media and Advertising February 2012 – Present (4 years 9 months) Global online media and advertising startup Might he be an employee of Phorm or PhluidMedia Inc, and be winding them up as a priority creditor due some wages/employee benefits? Not much point in going for any share options I suppose. I wonder if he'll get anything from winding up PhluidMedia Inc. while Andrew Croxson was a director of his new company? Perhaps he could send some of it to the BBC to cover their £120m losses on their failed Digital Media Initiative? I'm sure the license payers would be grateful. At present the situation does seem very "Fluid" Gosh - there's that word again... Let's hope the official receiver takes a close look at the whole story. From what I read of his time as an official receiver in Cambridge/East Anglia, he can be quite thorough, looking at the directors' behaviour. |
Posted at 31/5/2016 17:38 by pseudopwr There seem to be many, many hanging questions regarding Phorm IncBy design, I suppose. The share price has been an irrelevance for months, if not longer. For example, can I ask ... Is Phorm Inc still trading? Forget Phuid Media UK etc etc Is imarker still part of the interweb? and/or Phorm? What was/is insomnis? What, if anything, are insomnis.com doing these days? Where are/were they based? Maybe Austin Reed's orderly shutdown will ne more orderly .. Sad to see, but more orderly. |
Posted at 16/4/2016 21:36 by btcustomer Phorm are phinally phinished.So much for all those misleading ramps! The cash ran out. The revenues never arrived. The investors finally gave up. Even the CEO is gone - Phorm's phone will be answered by a NY litigator specialising in bankruptcy hearings. Bye. Parting is such sweet sorrow. Must go - I have a bottle of Kent sparkling wine to open! Phorm Corporation Limited Update and Resignation of Nominated Adviser 14/04/2016 9:00am UK Regulatory (RNS & others) Phorm Corp (LSE:PHRM) Historical Stock Chart 1 Month : From Mar 2016 to Apr 2016 Click Here for more Phorm Corp Charts. TIDMPHRM RNS Number : 2041V Phorm Corporation Limited 14 April 2016 14 April 2016 Phorm Corporation Limited ("Phorm" or the "Company") Financial and Operational Update and Resignation of Nominated Adviser Phorm (AIM: PHRM), an advertising-technolo Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings. Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM. The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation. A further announcement(s) will be made by the Company in due course as appropriate. -Ends- For further information please contact: Phorm Corporation Limited Thomas Baylis +1 516-357-3748 This information is provided by RNS The company news service from the London Stock Exchange END MSCIIMPTMBABMJF (END) Dow Jones Newswires April 14, 2016 05:00 ET (09:00 GMT) |
Posted at 15/4/2016 05:55 by 12bn bluecar1,this flea ridden dog is dead. It is no more. It is deceased! :)TIDMPHRMRNS Number : 2041V Phorm Corporation Limited 14 April 2016 14 April 2016 Phorm Corporation Limited ("Phorm" or the "Company") Financial and Operational Update and Resignation of Nominated Adviser Phorm (AIM: PHRM), an advertising-technolo Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings. Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM. The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation. A further announcement(s) will be made by the Company in due course as appropriate. -Ends- |
Posted at 04/2/2016 23:36 by btcustomer So the subscription from 18th Jan FAILED - and the undertakings given by the mysterious sole US investor both then and prior to 1st Feb were worthless - so the lawyers are now charging fees to try and suck out the money. I bet THEY don't get paid in shares!So those with money already sunk into the company, have had to cough up more cash and more loans and convert the earlier loans into yet more shares - otherwise their existing investments of millions of dollars would have evaporated in a bankruptcy. And now we await for the next begging bowl round - £2.5m POUNDS to be raised for more shares, by 24th Feb. I wonder who is going to cough up? Perhaps they need to include some thumb screws in the begging bowl kit? Are there enough gullible investors out there who haven't yet heard of Phorm and who won't expect awkward things like being told the full story of Phorm's inability to earn revenues, or why their R&D cost is so high year after year? On 10th Feb, shares in issue will be 1,050,777,150 - even with the withdrawl of the Jan 18th shares - the dilution continues and continues past the billion mark. And the investors are harder to find each time, and cough up less cash when they are found (or fail to cough up). The only currency Phorm seems to be able to spend is the currency of its own shares, which it prints relentlessly to solve every problem. I do have some questions which I know won't be answered. What on earth went wrong with the Jan 18th subscription? Who WAS this un-named sole US investor who Phorm are now having to sue? Did they even exist? What happened to that investment? Did the investor suddenly run out of money? Did they suddenly discover something they didn't know before? Was this a GENUINE share subscription? Or has something odd happened - to produce the rather convenient and pressurised circumstances where existing investors have been virtually FORCED to cough up loans and further investment, and provide yet another short term cash solution to Phorm's chronic inability to earn revenue, or else sit back and watch the company collapse and their entire shareholding become worthless. It rather reminds me of the missing China £20m share subscription back on the 1st June 2012 There was lots of hype about the potential of China at the time, even UKTI were dragged into the shouting game, and Phorm's share price went up dramatically - doubling from around 65p to 130p on the back of the announcements and undertakings on China, and the news of that £20m fundraise that never was. Then of course the whole thing folded and the money floated away across the China sea like 20m paper lanterns at a Chinese New Year festival, and the share price plummetted from 130p way down below the original 65p level after the announcement of failure in September 2012 - and eventually, we heard about "operational challenges" in China - and of course - the revenue never ever appeared and the supposed search for alternative sources of funding was abandoned. What on earth is going on, and isn't it time someone had a really good look at the finances and behaviour of this company over the last ten years, including the last few months - under the old board AND the new board? Or is this just what we have to put up with on the AIM cesspit? There sure is a very nasty smell. I think they are reasonable questions. I doubt anyone will provide an answer. |
Posted at 20/1/2016 18:47 by btcustomer Very low volumes, very significant percentage falls in share price The markets would appear to be getting less eneamoured of Phorm with every week that passes - lowest share price ever, lowest amount raised (and lowest issue price) of share issue ever (£700k at 1.55p). |
Posted at 07/1/2016 15:48 by 12bn So why isn't it a significant gain in the number of shares if you sell UK PHRM shares and buy US PHRM shares? I understand that each share is virtually worthless 3 x 0 still = 0 but if you think a miracle is going to happen and PHRM shares end up with some real value wouldn't you be better trading out of UK PHRM and into US PHRM? |
Posted at 05/1/2016 14:25 by btcustomer £45k WORTH?You're getting confused again IgbertSponk - it's always more challenging when you have to deal in facts. You seem to have priced the shares at 3p - which is NOT what they are WORTH. They have oscillated between 8p and 1.625p over the last three months on PHRM/LSE and between $0.075 and $0.0095 on PHORF/NASDAQ/OTC At PHORF prices TODAY ($0.0095/£0.00 At LSE PHRM prices today (£0.01625) 1.5m shares are WORTH £24,375. At £35.60 per share that would be a bit more of course (£53,400,000)- but IgbertSponk - you need to remember - the shares have gone DOWN since their peak in 2007. It looks like we will be setting new records every day now - record lows - unless Phorm can pull some "good news" out of their battered and very worn out begging bowl. |
Posted at 04/1/2016 16:20 by btcustomer Great timing for IgbertSponk - his post just depressed the share price a little bit more...A reminder of what his "year ahead" predictions are like: Here's what he said a year ago.... IgbertSponk - 24 Dec 2014 - 10:06:10 - 46529 of 50735 Cash surplus now approaching £3m as massive Crimbo advertising revenues roll in in China. Chinese New Year should see the whole business profitable and Phorm returning to lesser markets like Europe. IgbertSponk - 05 Jan 2015 - 09:26:02 - 46582 of 50735 No comment on this I see biggercapital $PHRM.L is my wtf idea ready to rocket next ROFL - Mr B is still looking for the key to "unlocking the value"... IgbertSponk - 06 Jan 2015 - 09:01:04 - 46613 of 50735 Cash surplus now estimated at £5m as exponential revenues ramp up. A lot of this will be reinvested in new China Telecom projects, so we'll have to wait for the maiden divi. Phorm begged another £17.5m during 2015 - IgbertSponk got that wrong then... and China phizzled out with "operational challenges" - so another IgbertSponk misfire... He's not very good at this is he? The year actually went like this... I can't find any poster called BTSaddoe - you really need to up your game IgbertSponk, maybe it's your lack of precision on details that sends your Phorm share price predictions so far astray? 23.53% down today so far... and no more good news - no revaluation of director's options - no "SomecompanyWejustMa No Russian DPI trial with Изв No announcement that the BOD will be paying £2m/mth for the privelige of serving? Why not just make a public announcement of a deal with GCHQ and NSA to provide DPI services to the secret squirrels under the Snoopers Charter for the next ten years? That would boost public confidence no end - after all - security is here to stay. Or might the idea of Phorm kit from Russia/China protecting the national infrastructure bring back unhappy memories of those internet outages in Korea, Romania, Brazil and Turkey that always seemed to happen around the time the Phorm DPI kit was being deployed? At the current price, a £2m share issue would require 123m new shares, a 12% dilution. And then they'd have to do it all over again... Unless of course, the revenue is flowing in an unprecedented manner? Anyone seen the 2015 revenue figures? |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions